Electrophysiological and neurochemical effects of long-term vagus nerve stimulation on the rat monoaminergic systems

International Journal of Neuropsychopharmacology

Volumn 16, Issue 2, 2013, Pages 459-470

  Manta, Stella ^a   El Mansari, Mostafa ^a   Debonnel, Guy ^b   Blier, Pierre ^a,b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Department of Cellular and Molecular Medicine ^*  (Canada)

Author keywords

Depression; electrophysiology; microdialysis; monoamines; vagus nerve stimulation

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; MONOAMINE; NORADRENALIN; SEROTONIN;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; DEPRESSION; DORSAL RAPHE NUCLEUS; ELECTROCHEMICAL DETECTION; EXTRACELLULAR SPACE; HIPPOCAMPAL CA3 REGION; MALE; MICRODIALYSIS; MONOAMINERGIC SYSTEM; NEUROCHEMISTRY; NONHUMAN; NORADRENALIN BRAIN LEVEL; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SPIKE; VAGUS NERVE; VAGUS NERVE STIMULATION; VENTRAL TEGMENTUM;

ACTION POTENTIALS; AFFERENT PATHWAYS; ANALYSIS OF VARIANCE; ANIMALS; BIOGENIC MONOAMINES; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR FLUID; MALE; MICRODIALYSIS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VAGUS NERVE STIMULATION;

EID: 84875926850     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145712000387     Document Type: Article

References (65)

1. Aman TK, Shen RY, Haj-Dahmane S (2007). D2-like dopamine receptors depolarize dorsal raphe serotonin neurons through the activation of nonselective cationic conductance. Journal of Pharmacology and Experimental Therapeutics 320, 376-385.
2. Ashton AK (2010). Depressive relapse after vagal nerve stimulator explantation. American Journal of Psychiatry 167, 719-720.
3. Bajbouj M, Merkl A, Schlaepfer TE, Frick C, et al. (2010). Two-year outcome of vagus nerve stimulation in treatment-resistant depression. Journal of Clinical Psychopharmacology 30, 273-281.
4. Baraban JM, Aghajanian GK (1980). Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-Adrenoceptor antagonists. Neuropharmacology 19, 355-363.
5. Bel N, Artigas F (1993). Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15, 243-245.
6. Blier P, Briley M (2011). The noradrenergic symptom cluster: clinical expression and neuropharmacology. Journal of Neuropsychiatric Disease and Treatment 7, 15-20.
7. Blier P, de Montigny C (1994). Current advances and trends in the treatment of depression. Trends in Pharmacological Sciences 15, 220-226.
8. Blier P, Pineyro G, el Mansari M, Bergeron R, et al. (1998). Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Annals of the New York Academy of Sciences 861, 204-216.
9. Bosker F, Klompmakers A, Westenberg H (1994). Extracellular 5-hydroxytryptamine in median raphe nucleus of the conscious rat is decreased by nanomolar concentrations of 8-hydroxy-2-(di-n-propylamino) tetralin and is sensitive to tetrodotoxin. Journal of Neurochemistry 63, 2165-2171.
10. Bymaster FP, Zhang W, Carter PA, Shaw J, et al. (2002). Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology (Berlin) 160, 353-361.
11. Carlson JN, Visker KE, Nielsen DM, Keller RW, et al. (1996). Chronic antidepressant drug treatment reduces turning behavior and increases dopamine levels in the medial prefrontal cortex. Brain Research 707, 122-126.
12. Carpenter LL, Moreno FA, Kling MA, Anderson GM, et al. (2004). Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-Aminobutyric acid concentrations in depressed patients. Biological Psychiatry 56, 418-426.
13. Ceglia I, Acconcia S, Fracasso C, Colovic M, et al. (2004). Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors. British Journal of Pharmacology 142, 469-478.
14. Chernoloz O, El Mansari M, Blier P (2009). Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorder. Psychopharmacology (Berlin) 206, 335-344.
15. Chernoloz O, El Mansari M, Blier P (2011). Long-term administration of the dopamine D3/2 receptor agonist pramipexole increases dopamine and serotonin neurotransmission in the male rat forebrain. Journal of Psychiatry and Neuroscience 37, 113-121.
16. Clark RN, Ashby CR, Dewey SL, Ramachandran PV, et al. (1996). Effect of acute and chronic fluoxetine on extracellular dopamine levels in the caudate-putamen and nucleus accumbens of rat. Synapse 23, 125-131.
17. Conway CR, Chibnall JT, Tait RC (2008). Vagus nerve stimulation for depression: a case of a broken lead, depression relapse, revision surgery, and restoration of patient response. Brain Stimulation 1, 227-228.
18. Corrigan MH, Denahan AQ, Wright CE, Ragual RJ, et al. (2000). Comparison of pramipexole, fluoxetine, and placebo in patients with major depression. Depression and Anxiety 11, 58-65.
19. Curet O, de Montigny C (1988a). Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. I. Receptors mediating the effect of microiontophoretically applied norepinephrine. Brain Research 475, 35-46.
20. Curet O, de Montigny C (1988b). Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. II. Receptors mediating the effect of synaptically released norepinephrine. Brain Research 475, 47-57.
21. Dorr AE, Debonnel G (2006). Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. Journal of Pharmacology and Experimental Therapeutics 318, 890-898.
22. Dremencov E, El Mansari M, Blier P (2007). Noradrenergic augmentation of escitalopram response by risperidone: electrophysiologic studies in the rat brain. Biological Psychiatry 61, 671-678.
23. Dunlop BW, Nemeroff CB (2007). The role of dopamine in the pathophysiology of depression. Archives of General Psychiatry 64, 327-337.
24. El Mansari M, Guiard BP, Chernoloz O, Ghanbari R, et al. (2010). Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder. CNS Neuroscience and Therapeutics 16, e1-e17.
25. El Mansari M, Sanchez C, Chouvet G, Renaud B, et al. (2005). Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain. Neuropsychopharmacology 30, 1269-1277.
26. Fawaz CS, Martel P, Leo D, Trudeau LE (2009). Presynaptic action of neurotensin on dopamine release through inhibition of D(2) receptor function. BMC Neuroscience 10, 96.
27. Franberg O, Marcus MM, Ivanov V, Schilstrom B, et al. (2009). Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms. Psychopharmacology (Berlin) 204, 251-264.
28. Gardier AM, David DJ, Jego G, Przybylski C, et al. (2003). Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice. Journal of Neurochemistry 86, 13-24.
29. Ghanbari R, El Mansari M, Blier P (2011). Enhancement of serotonergic and noradrenergic neurotransmission in the rat hippocampus by sustained administration of bupropion. Psychopharmacology (Berlin) 217, 61-73.
30. Grace AA, Bunney BS (1983). Intracellular and extracellular electrophysiology of nigral dopaminergic neurons-3. Evidence for electrotonic coupling. Neuroscience 10, 333-348.
31. Grace AA, Bunney BS (1984). The control of firing pattern in nigral dopamine neurons: burst firing. Journal of Neuroscience 4, 2877-2890.
32. Guiard BP, David DJ, Deltheil T, Chenu F, et al. (2008). Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype. International Journal of Neuropsychopharmacology 11, 79-92.
33. Gundlah C, Hjorth S, Auerbach SB (1997). Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment. Neuropharmacology 36, 475-482.
34. Haddjeri N, Blier P, de Montigny C (1998). Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. Journal of Neuroscience 18, 10150-10156.
35. Haj-Dahmane S (2001). D2-like dopamine receptor activation excites rat dorsal raphe 5-HT neurons in vitro. European Journal of Neuroscience 14, 125-134.
36. Hajos-Korcsok E, McTavish SF, Sharp T (2000). Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine. European Journal of Pharmacology 407, 101-107.
37. Hery F, Faudon M, Fueri C (1986). Release of serotonin in structures containing serotoninergic nerve cell bodies: dorsalis raphe nucleus and nodose ganglia of the cat. Annals of the New York Academy of Sciences 473, 239-255.
38. Invernizzi R, Bramante M, Samanin R (1995). Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram. Brain Research 696, 62-66.
39. Jones BE, Moore RY (1977). Ascending projections of the locus coeruleus in the rat. II. Autoradiographic study. Brain Research 127, 25-53.
40. Kandel ER, Spencer WA (1961). Electrophysiology of hippocampal neurons. II. After-potentials and repetitive firing. Journal of Neurophysiology 24, 243-259.
41. Kasper S, Meshkat D, Kutzelnigg A (2011). Improvement of the noradrenergic symptom cluster following treatment with milnacipran. Journal of Neuropsychiatric Disease and Treatment 7, 21-27.
42. Kawahara Y, Kawahara H, Kaneko F, Tanaka M (2007). Long-term administration of citalopram reduces basal and stress-induced extracellular noradrenaline levels in rat brain. Psychopharmacology (Berlin) 194, 73-81.
43. Koch S, Perry KW, Nelson DL, Conway RG, et al. (2002). R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study. Neuropsychopharmacology 27, 949-959.
44. Kreiss DS, Lucki I (1995). Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. Journal of Pharmacology and Experimental Therapeutics 274, 866-876.
45. Lambert G, Johansson M, Agren H, Friberg P (2000). Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders. Archives of General Psychiatry 57, 787-793.
46. Manta S, Dong J, Debonnel G, Blier P (2009a). Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation. Journal of Psychiatry and Neuroscience 34, 272-280.
47. Manta S, Dong J, Debonnel G, Blier P (2009b). Optimization of vagus nerve stimulation parameters using the firing activity of serotonin neurons in the rat dorsal raphe. European Neuropsychopharmacology 19, 250-255.
48. Martinez JM, Zboyan HA (2006). Vagus nerve stimulation therapy in a patient with treatment-resistant depression: a case report of long-term follow-up and battery end-of-service. CNS Spectrum 11, 143-147.
49. Merschdorf U, Berg D, Csoti I, Fornadi F, et al. (2003). Psychopathological symptoms of depression in Parkinson's disease compared to major depression. Psychopathology 36, 221-225.
50. Mitani H, Shirayama Y, Yamada T, Kawahara R (2006). Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients. Progress in Neuropsychopharmacology and Biological Psychiatry 30, 531-534.
51. Mnie-Filali O, Faure C, Lambas-Senas L, ElMansari M, et al. (2011). Pharmacological blockade of 5-HT(7) receptors as a putative fast acting antidepressant strategy. Neuropsychopharmacology 36, 1275-1288.
52. Paxinos G, Watson C (2007). Paxinos & Watson the Rat Brain in Stereotaxic Coordinates, 6th edn. Amsterdam: Elsevier.
53. Pineyro G, Blier P (1999). Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacological Reviews 51, 533-591.
54. Raedt R, Clinckers R, Mollet L, Vonck K, et al. (2011). Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model. Journal of Neurochemistry 117, 461-469.
55. Ranck JB (1973). Studies on single neurons in dorsal hippocampal formation and septum in unrestrained rats. I. Behavioral correlates and firing repertoires. Experimental Neurology 41, 461-531.
56. Rea K, Folgering J, Westerink BH, Cremers TI (2010). Alpha1-Adrenoceptors modulate citalopram-induced serotonin release. Neuropharmacology 58, 962-971.
57. Roosevelt RW, Smith DC, Clough RW, Jensen RA, et al. (2006). Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat. Brain Research 1119, 124-132.
58. Sackeim HA, Rush AJ, George MS, Marangell LB, et al. (2001). Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 25, 713-728.
59. Santarelli L, Saxe M, Gross C, Surget A, et al. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805-809.
60. Schildkraut JJ (1974). Biogenic amines and affective disorders. Annual Review of Medicine 25, 333-348.
61. Schlaepfer TE, Frick C, Zobel A, Maier W, et al. (2008). Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychological Medicine 38, 651-661.
62. Szabo ST, de Montigny C, Blier P (2000). Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors. International Journal of Neuropsychopharmacology 3, 1-11.
63. Tanda G, Bassareo V, Di Chiara G (1996a). Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat. Psychopharmacology (Berlin) 123, 127-130.
64. Tanda G, Frau R, Di Chiara G (1996b). Chronic desipramine and fluoxetine differentially affect extracellular dopamine in the rat prefrontal cortex. Psychopharmacology (Berlin) 127, 83-87.
65. Ungless MA, Magill PJ, Bolam JP (2004). Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science 303, 2040-2042.